Biotech | November 12, 2025
Samsung Epis launches new biotech subsidiary Epis NexLab
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
The payment is in accordance with the agreed contractual terms
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
